Abstract
The metabolic syndrome (MetS) may contribute to the increased cardiovascular risk in systemic lupus erythematosus (SLE). We examined the association between MetS and disease activity, disease phenotype and corticosteroid exposure over time in patients with SLE.
Original language | English |
---|---|
Journal | Annals of the Rheumatic Diseases |
DOIs | |
Publication status | Published - 1 Apr 2014 |